These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 17981831
1. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. Yakupogullari Y, Poirel L, Bernabeu S, Kizirgil A, Nordmann P. J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831 [No Abstract] [Full Text] [Related]
2. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Pasteran F, Faccone D, Petroni A, Rapoport M, Galas M, Vázquez M, Procopio A. Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342 [No Abstract] [Full Text] [Related]
3. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. Bahar G, Mazzariol A, Koncan R, Mert A, Fontana R, Rossolini GM, Cornaglia G. J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017 [No Abstract] [Full Text] [Related]
4. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. Wang C, Cai P, Chang D, Mi Z. J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065 [No Abstract] [Full Text] [Related]
5. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S. J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142 [Abstract] [Full Text] [Related]
6. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Khosravi AD, Mihani F. Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848 [Abstract] [Full Text] [Related]
7. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country. Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087 [Abstract] [Full Text] [Related]
8. [Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future]. Oliver A. Enferm Infecc Microbiol Clin; 2009 May; 27(5):255-6. PubMed ID: 19361889 [No Abstract] [Full Text] [Related]
9. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia. Ohlasova D, Kmet V, Niks M. Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230 [No Abstract] [Full Text] [Related]
10. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. Diagn Microbiol Infect Dis; 2009 Aug; 64(4):458-61. PubMed ID: 19631102 [Abstract] [Full Text] [Related]
11. Prevalence and molecular characterisation of metallo-beta-lactamase producing strains of imipenem-resistant Pseudomonas aeruginosa in Turkey. Yilmaz NO, Agus N, Bozcal E, Uzel A. Indian J Med Microbiol; 2014 Aug; 32(3):349-50. PubMed ID: 25008840 [No Abstract] [Full Text] [Related]
12. Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Corvec S, Poirel L, Decousser JW, Allouch PY, Drugeon H, Nordmann P. Clin Microbiol Infect; 2006 Sep; 12(9):941-2. PubMed ID: 16882306 [No Abstract] [Full Text] [Related]
13. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China. Chao Z, Xiao-Feng W, Dan-Hong S, Jin-Ping Y, Nan-Shan Z. Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819 [No Abstract] [Full Text] [Related]
14. VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey. Poirel L, Yakupoğullari Y, Kizirgil A, Dogukan M, Nordmann P. Int J Antimicrob Agents; 2009 Mar; 33(3):287. PubMed ID: 18805676 [No Abstract] [Full Text] [Related]
15. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa. Fournier D, Hocquet D, Dehecq B, Cholley P, Plésiat P. J Antimicrob Chemother; 2010 Feb; 65(2):364-5. PubMed ID: 20008045 [No Abstract] [Full Text] [Related]
16. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea. Suk SE, Yoo JS, Lee JK, Lee KM, Chung GT, Shin ES, Han SY, Lee SH, Kim J, Lee YS. J Microbiol Biotechnol; 2007 Oct; 17(10):1733-7. PubMed ID: 18156795 [Abstract] [Full Text] [Related]
17. Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps. Ratkai C, Nagy E, Peixe L, Bertalan V, Hajdú E. J Infect; 2010 Dec; 61(6):511-2. PubMed ID: 20951729 [No Abstract] [Full Text] [Related]
18. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. Yan JJ, Tsai SH, Chuang CL, Wu JJ. J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245 [Abstract] [Full Text] [Related]